FDA Approves Drug for Active Psoriatic Arthritis
July 6th 2017The FDA has approved Bristol-Myers Squibb’s abatacept (Orencia) in both intravenous (IV) and subcutaneous (SC) injections forms for the treatment of active Psoriatic Arthritis (PsA) in adults. The approval is the third autoimmune disease indication for Orencia.
Read More
Study: Pharmacists Often Have Better Penicillin Allergy Knowledge Than Other Health Professionals
June 20th 2017Pharmacists appear to have a better understanding of penicillin allergies than other health care professionals, according to study that included 276 surveys completed by non-allergist physicians, nurse practitioners, and pharmacists at Rochester Regional Health.
Read More
Oral Contraceptives Recalled for Out-of-Sequence Packaging
May 30th 2017Lupin Pharmaceuticals Inc. has issued a nationwide recall of 1 lot of its oral contraceptive tablets Mibelas 24 Fe (norethindrone acetate and ethinyl estradiol chewable tablets and ferrous fumarate) because of out-of-sequence tablet packaging and missing expiration and lot information.
Read More